HUI-JU LIU: Open Payments
NPI 1245884485 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 45 payments from 12 companies in 2025. Trend: 2023 $1,496 · 2024 $1,418 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $270 |
| Novartis Pharmaceuticals Corporation | 9 | $215 |
| Janssen Biotech, Inc. | 7 | $162 |
| Gilead Sciences, Inc. | 5 | $124 |
| ABBVIE INC. | 6 | $120 |
| GlaxoSmithKline, LLC. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Genentech USA, Inc. | 3 | $64 |
| Exact Sciences Corporation | 2 | $58 |
| TerSera Therapeutics LLC | 2 | $41 |
Products named: Fabhalta, OTEZLA, REPATHA, EPKINLY, RYBREVANT, BREZTRI, Tecentriq, TECVAYLI.
Industry payments across NY — which companies pay providers there.
